EODData

OTCBB, DVHGF: Devonian Health Group Inc

19 Sep 2025
LAST:

0.0711

CHANGE:
 0.11
OPEN:
0.0711
HIGH:
0.0711
ASK:
0.0000
VOLUME:
10K
CHG(%):
60.50
PREV:
0.1800
LOW:
0.0711
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

COMPANY PROFILE

Name:Devonian Health Group Inc
About:Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinical trial for HFS associated to chemotherapy; and in phase 2/3 clinical trial for Radiodermatitis associated to radiotherapy, as well as in phase 2a clinical trial for ulcerative colitis. The company also develops Pantoprazole Magnesium for the treatment of gastric reflux; Cleo-35 for the treatment of hormonal acne in women; Dexlansoprazole; R-Spinasome anti-aging cream, serum, and regenerating creams; and anti-aging products, including day, night, and eye creams under the Purgenesis name. Devonian Health Group Inc. is headquartered in Québec, Canada.
Sector:Healthcare
Industry:Biotechnology
Address:360, rue des Entrepreneurs, Québec, QC, Canada, G5V 4T1
Website:https://groupedevonian.com
FIGI:BBG014KCV8Z1

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:0.1489.9%
MA10:0.1385.9%
RSI14:48.06
WPR14:-64.06
MTM14:-0.09
ROC14:-0.56 
ATR:0.05 
Week High:0.070.0%
Week Low:0.070.0%